Identity for Alaxia, a French private biotech company developing therapeutic solutions for respiratory diseases based on its proprietary peroxidase platform. The most advanced drug candidate, ALX-009, is an antimicrobial innovative compound aiming at treating cystic fibrosis, including the most resistant bacterial strains.
Based in Lyon (France) Alaxia needed its logo to be designed to improve readability, along with an brand guideline and web design.
http://www.alaxia-pharma.eu
